Park et al. showed that OPG is not a valuable prognostic factor on multivariate analysis for skeletal-disease free survival, disease-free survival and overall survival in a study based on the analysis of tissue microarrays obtained from 185 patients with primary breast cancer. This evidence concerns the gene TNFRSF11B and breast cancer.